Advanced Search
ORIGINAL ARTICLE
Korean J Pediatr 2009 January;52(1) :61-67.
doi:https://doi.org/10.3345/kjp.2009.52.1.61
Drug resistance of Mycobacterium tuberculosis in children
Soo Jin Lee (Lee SJ)1, Young Min Ahn (Ahn YM)1, Hee Jin Kim (Kim HJ)2
1Departments of Pediatrics, College of Medicine, Eulji University, Daejeon, Korea
2Department of Epidemiology, The Korean Institute of Tuberculosis, Seoul, Korea
Corresponding Author: Young Min Ahn ,Email: aym3216@eulji.ac.kr
Copyright © 2009 by The Korean Pediatric Society
ABSTRACT
Purpose : The rate of drug-resistant tuberculosis (DR-TB) in children is an indicator of the effectiveness of TB control programs in the community. This study aimed to assess the prevalence of DR-TB in children and evaluate TB management. Methods : Between January 1999 and July 2007, drug susceptibility tests for anti-TB drugs were employed for patients aged less than 19 years with culture-positive TB. Results : A total of 607 cases (16.6%) were resistant to at least one anti-TB drug as follows: isoniazid (INH; 13.8%), rifampin (8.9%), pyrazinamide (4.2%), streptomycin (3.7%), ethambutol (EMB; 5.9%), and para-aminosalicylic acid (PAS; 1.9%). Multidrug-resistant (MDR) TB was found in 276 cases (7.6%); extensive drug resistant (XDR) TB, in 5 cases (0.2%). The rate of resistance to at least one anti-TB drug in children aged >15 years (16.1%) was significantly lower than that in children aged <15 years (20.5%) (P=0.016). The rate of resistance to at least one anti-TB drug and multidrug-resistance in this survey decreased significantly (P<0.001) as compared to the previous survey (1987-1995). The rate of resistance to INH, EMB, and PAS also significantly decreased (P<0.05). Conclusion : The rate of DR-TB in children in Korea has decreased over time; however, it remains higher than that in other countries. MDR-TB and XDR-TB are the emerging problems in Korean children. Therefore, the selection of effective drugs through drug susceptibility tests and evaluating risk factors of resistant TB is essential to successful therapy and a decreased incidence of DR-TB.
Keywords: Tuberculosis | Drug-resistant | Multidrug-resistant tuberculosis | Children
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
  Print
Share:      
METRICS
1,659
View
6
Download
Clinical manifestation of Campylobacter enteritis in children  2018 March;61(3)
Treatment of obstructive sleep apnea in children  2010 October;53(10)
Treatment of latent tuberculous infection in children and adolescent  2009 May;52(5)
Characteristics of tuberculosis in children and adolescents  2009 May;52(5)
Diagnosis and treatment of nocturnal enuresis in children  2008 November;51(11)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at http://submit.kjp.or.kr, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact: kjpped@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail: kjpped@gmail.com
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.